Watch the experts discuss additional SKYRIZI study results:
Dr. Melinda Gooderham, an expert dermatologist, discusses her experience with the UltIMMa PsO studies.
Professors Strober and Van de Kerkhof, two expert dermatologists, discuss the IMMhance PsO trial.
Dr. Richard Warren, an expert dermatologist, discusses data from the IMMerge PsO study.
Professor Kim Papp, principal investigator of KEEPsAKE-1 and -2, summarizes the results of the Phase 3 PsA studies.
You may also be interested in
Find out more about SKYRIZI
Reference
- SKYRIZI [Summary of Product Characteristics]. AbbVie Ltd; February 2023.